Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1996-02-09
1997-09-23
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514613, A61K 3116, A61K 31165
Patent
active
056705450
ABSTRACT:
Bucillamine and N-2,2-dimethyl-3-mercaptopropionyl)-L-cysteine or related compounds can be used to prevent damage to living tissue from the formation or presence of reactive oxygen species. These reactive oxygen species are formed when tissue is first rendered hypoxic due to interruption of blood flow and then reoxygenated by restoration of blood flow. In particular, the invention is directed to the administration of bucillamine and N-2,2-dimethyl-3-mercaptopropionyl)-L-cysteine prior to or coincidental with reperfusion to prevent damage to myocardium from formation of reactive oxygen species. Also presented are application of these compounds to similar ischemia-related cell injury in other organs.
REFERENCES:
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4137420 (1979-01-01), Fujita et al.
patent: 4241086 (1980-12-01), Iwao et al.
patent: 4255446 (1981-03-01), Iwao et al.
patent: 4305958 (1981-12-01), Fujita et al.
patent: 4517123 (1985-05-01), Iso et al.
patent: 5266595 (1993-11-01), Baba et al.
patent: 5292926 (1994-03-01), Morita et al.
Nishida, et al. (1987) "Peroxidative injury of the mitochondrial respiratory chain during reperfusion of hypothermic rat liver," Biochem.Biophys.Acta, 890:82-88.
Shuter, et al. (1990) "Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy," Free Rad. Res. Comms., 9:223-232.
Lesnefsky, et al. (1989) "Superoxide dismutase decreases early reperfusion release of conjugated dienes following regional canine ischemis," Basic Res. Cardiol., 84:191-19.
Byler et al. (1994) "Hydrogen peroxide cytotoxicity in cultured cardiac myocytes is iron dependent," Am.J.Physiol., 266:H121-H127.
Hogg et al. (1992) "Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide," Biochemical J., 281:419-424.
Traystman et al. (1991) "Oxygen radical mechanisms of brain injury following ischemia and reperfusion," J.Amer.Phys.Soc. 71:1185-1195.
Paller et al. (1991) "Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation," Kidney Int. 40:1041-1049.
Matsushima et al. (1992) "Protection by coenzyme Q.sub.10 of canine myocardial reperfusion injury after preservation," J. Thorax. Cardiovasc. Surgery 103:945951.
Davenport et al. (1995) "Measurement of malondialdeyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function," Clinical Transplantation, 9:171-175.
Dauber et al. (1991) "Reactive oxygen metabolite scavengers decrease functional coronary microvascular injury due to ischemia-reperfusion," J.Amer.Phys.Soc. 260:H42-H49.
Quinn et al. (1987) "Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis," Proc. Natl. Acad. Sci., USA 84:2995-2998.
Sobotka et al. (1993) "Elevated Breath Pentane in Heart Failure Reduced by Free Radical Scavenger," Free Radical Biol. Med. 14:643-647.
Munzel et al. (1995) "Evidence for Enhanced Vascular Superoxide Anion Production in Nitrate Tolerance," J. Clinical Invest. 95:187-194.
Carrea et al. (1991) "Reduction of Canine Myocardial Infaret Size by a Diffusible Reactive Oxygen Metabolite Scavenger," Circ. Res. 68:1652-1659.
Horwitz et al. (1994) "Marked Reduction in Myocardial Infaret Size Due to Prolonged Infusion of an Antioxidant During Reperfusion," Circulation 89:1792-1801.
Fuchs et al. (1988) "Mitochondrial Sulfhydryl Groups under Oligomycin-Inhibited, Aging, and Uncoupling Conditions: Beneficial Influence of Cardioprotective Drugs," Archives of Biochem.Biophysics 266(1):83-88.
Fuchs et al. (1985) "2-Mercaptopropionylglycine and Related Compounds in Treatment of Mitochondrial Dysfunction and Postischemic Myocardial Damage," Arzneim-Forsch Drug Research 35:1394-1402.
Freisleben, H-J. et al. (1987) "Decrease of Mitochondrial Thiols Under Uncoupling Oligomycin Inhibited and Aging Conditions: Protective Properties of Anti-Anginal Drugs," Hoppe-Seyler's Zeitschrift Physiol Chem. 368:1253. Abstract of 63rd Conference of the Gesellschaft fur Biologische Chemie.
Board of Regents of the University of Colorado
Jordan Kimberly
LandOfFree
Method for the treatment of ischemic disease and reperfusion inj does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of ischemic disease and reperfusion inj, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of ischemic disease and reperfusion inj will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938850